Related Experiment Video
Updated: Jun 30, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Pediatric Reference and Optimal Curves for Hemoglobin
Vid Bijelic1,2, Franco Momoli1, Mira Liebman3
1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Insights
This study developed new hemoglobin reference curves (RCs) and optimal curves (OCs) for children, improving accuracy over traditional methods. These curves offer better clinical context and highlight potential differences with current World Health Organization (WHO) thresholds.
Area of Science:
- Pediatric Hematology
- Clinical Biochemistry
- Biostatistics
Background:
- Reference intervals (RIs) are crucial for interpreting pediatric laboratory results.
- Traditional RIs require age and sex partitioning, leading to limited sample sizes and imprecise estimates.
- Hemoglobin level modeling as a continuous function of age addresses these limitations.
Purpose of the Study:
- To establish sex-specific hemoglobin reference curves (RCs) for children.
- To estimate hemoglobin optimal curves (OCs) using health-based criteria.
- To complement World Health Organization (WHO) hemoglobin thresholds and inform reporting standards.
Main Methods:
- Cross-sectional study of healthy Canadian children aged 2 weeks to 10 years.
- Nonparametric quantile regression with restricted cubic splines to estimate RCs and OCs.
- Development of a web-based platform for visualizing curves and calculating limits.
Main Results:
- Hemoglobin RCs and OCs were estimated for 4597 and 3426 children, respectively.
- Optimal curves (OCs) showed sex-specific differences compared to reference curves (RCs), particularly in younger children.
- World Health Organization (WHO) thresholds were often higher than the lower limits of the OCs, especially in younger age groups.
Conclusions:
- Modeled hemoglobin RCs overcome limitations of traditional pediatric RIs.
- Optimal curves (OCs) provide additional clinical context beyond RIs.
- Findings suggest potential misalignments between new curves and existing WHO thresholds, particularly for younger children.
Importance:
Clinicians rely on reference intervals (RIs) to interpret laboratory test results. In pediatric populations, estimating RIs typically requires partitioning data by age, sex, and other relevant factors, which can lead to limited sample size and imprecise estimates; these limitations are addressed by using curve estimation, modeling hemoglobin level as a continuous function of age.
Objective:
To establish hemoglobin reference curves (RCs) for children and to complement recently published World Health Organization (WHO) thresholds by estimating hemoglobin optimal curves (OCs) that may inform more appropriate reporting standards.
Design, Setting, And Participants:
This cross-sectional study included healthy Canadian children aged 2 weeks through 10 years attending scheduled primary care visits from June 3, 2008, to February 26, 2020, in Toronto, Ontario, Canada. Data were analyzed from October 16, 2024, to February 1, 2026.
Exposure:
Blood samples were collected and analyzed for hemoglobin, ferritin, and C-reactive protein levels.
Main Outcomes And Measures:
Parents completed a questionnaire to collect variables used as optimality criteria. Sex-specific RCs and OCs were estimated using nonparametric quantile regression with restricted cubic splines. RCs were based on the full sample, whereas OCs excluded children with indicators of suboptimal iron status. A web-based platform was developed to visualize these curves and calculate sex-specific reference and optimal limits by age. Findings were examined in relation to WHO hemoglobin thresholds.
Results:
Blood samples from 4597 children (2451 males [53%]; median age, 38 months [IQR, 18-63 months]) were used to estimate hemoglobin RCs, and samples from a subgroup of 3426 children (1798 males [52%]; median age, 45 months [IQR, 24-68 months]) were used to estimate OCs. For females, lower OC hemoglobin limits were slightly below the lower RC limits up until age 2 years and became higher after age 6 years (eg, at 6 months, the OC lower limit was 9.91 g/dL [90% CI, 9.70-10.13 g/dL] vs 10.00 g/dL [90% CI, 9.78-10.23 g/dL] for RC). For males, lower OC limits were higher than lower RC limits until age 20 months (eg, at 6 months, the OC lower limit was 9.74 g/dL [90% CI, 9.46-10.02 g/dL] vs 9.28 g/dL [90% CI, 8.94-9.63 g/dL] for RC) and were similar afterwards. Differences in the upper limits were minimal for both sexes. WHO hemoglobin thresholds were consistently higher than lower limits of OCs across all ages but exceeded the 5th percentile curve only among children aged 5 through 10 years for both sexes (eg, for males aged 1 year, the OC lower limit was 10.06 g/dL [90% CI, 9.92-10.21 g/dL] vs the 10.5 g/dL WHO threshold).
Conclusions And Relevance:
This cross-sectional study estimated sex-specific pediatric RCs for hemoglobin, modeled as a continuous function of age, to eliminate the need for age partitioning and overcome the associated sample size limitations. OCs, developed using health-based criteria, offered additional clinical context beyond traditional RIs. The findings highlight potential misalignments with existing WHO thresholds, particularly at younger ages.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
